Company / Depreciation & Amortization
Moderna Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$211.0M
FY2025
5-year range
$31.0M / $617.0M
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
#14 of 168
Health Care
What the data says
Among 168 Health Care companies, Moderna is in the bottom 8% for depreciation & amortization. Improved from $617M to $211M over the past 2 years.
Based on SEC 10-K filings.
$211M in FY2025 with a 5-year CAGR of +46.8%. Top quartile in the Health Care sector.
Improved from $617M to $211M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +89.5%
- 5-Year CAGR
- +46.8%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 92% of 168This company $211.0M Sector average $212.9M
▼
In line with sector average
Key checks
Key Insights
- 5-year CAGR of +46.8%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 14.1% year-over-year.
- Ranks #14 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $211.0M | +14.1% |
| FY2024 | $185.0M | -70.0% |
| FY2023 | $617.0M | +1890.3% |
| FY2022 | $31.0M | +0.0% |
| FY2021 | $31.0M | +0.0% |
| FY2020 | $31.0M | +0.0% |
| FY2019 | $31.0M | +24.7% |
| FY2018 | $24.9M | +21.1% |
| FY2017 | $20.5M | +35.9% |
| FY2016 | $15.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026